William G. Goodman

Amgen (United States) — United States

Medicine · Health Sciences

70h-index19.5kcitations289works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parathyroid Disorders and Treatments(149), Vitamin D Research Studies(50), Biblical Studies and Interpretation(48), Archaeology and Historical Studies(47), Pharmacological Effects and Toxicity Studies(36)

Publications289 total

Correction: Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel
PLoS ONE·2025Open Access
Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel
PLoS ONE·2025· 1 citedOpen Access
Etelcalcetide Versus Cinacalcet in Hemodialysis Patients in the United States: A Facility Calcimimetic Approach to Assess Real-World Effectiveness
Kidney Medicine·2022· 8 citedOpen Access
Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real‐world clinical practice and outcomes
Hemodialysis International·2021· 1 cited
US Hemodialysis Facilities Switching from Cinacalcet to Etelcalcetide: Impact on Parathyroid Hormone (PTH) Levels
Journal of the American Society of Nephrology·2021
PDB30 Calcimimetic Use in United States (US) Hemodialysis Facilities in First Two Years after Launch of Etelcalcetide
Value in Health·2021
FC 078REAL-WORLD EFFECTIVENESS OF ETELCALCETIDE VS. CINACALCET IN US HEMODIALYSIS PATIENTS: A FACILITY CALCIMIMETIC PREFERENCE APPROACH
Nephrology Dialysis Transplantation·2021
MO571PRACTICE PATTERNS ON THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN THE UNITED STATES: RESULTS FROM A MODIFIED DELPHI PANEL
Nephrology Dialysis Transplantation·2021
Herald of Holiness - July 15, 1982
2020
Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism
Calcified Tissue International·2017· 48 citedOpen Access
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial
RWTH Publications (RWTH Aachen)·2016· 2 cited
Determination of Etelcalcetide Biotransformation and Hemodialysis Kinetics to Guide the Timing of Its Dosing
Kidney International Reports·2016· 19 citedOpen Access
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial
RWTH Publications (RWTH Aachen)·2016
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the <scp>EVOLVE</scp> trial
Hemodialysis International·2015· 18 citedOpen Access
Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures
Calcified Tissue International·2015· 92 cited
Cardiovascular and Renal Outcomes Trials—Is There a Difference?
The American Journal of Cardiology·2015· 3 citedOpen Access
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis
Circulation·2015· 299 citedOpen Access
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial
Journal of Human Hypertension·2015· 15 cited
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Queensland's institutional digital repository (The University of Queensland)·2015· 6 cited
FP403AMG 416, A PEPTIDE AGONIST OF THE CALCIUM-SENSING RECEPTOR, PREVENTED VASCULAR CALCIFICATION IN A RAT MODEL OF UREMIA INDUCED BY ADENINE DIET
Nephrology Dialysis Transplantation·2015Open Access
page 1 of 15Next →

Frequent Co-authors

Isidro B. Salusky(11), Sharon M. Moe(9), Barbara Gales(7), Geoffrey A. Block(7), Glenn M. Chertow(7), Jack W. Coburn(7), Tilman B. Drüeke(6), Stewart A. Turner(6), Beatriz D. Kuizon(5), Gérard M. London(5), Jorge A. Ramirez(5), John Cunningham(4), Kévin Martin(4), Bastian Dehmel(4), Patrick S. Parfrey(4), Kenneth W. Mahaffey(4), David C. Wheeler(4), Patrick C. D’Haese(4), Marc E. De Broe(4), Stuart M. Sprague(3)